Literature DB >> 30579282

International practice variation in postoperative imaging of chronic subdural hematoma patients.

Alexander F C Hulsbergen1,2, Sandra C Yan1, Brittany M Stopa1, Aislyn DiRisio1, Joeky T Senders1,2, Max J van Essen2, Stéphanie M E van der Burgt1,3, Timothy R Smith1, William B Gormley1, Marike L D Broekman1,2,4,5.   

Abstract

OBJECTIVE: The value of CT scanning after burr hole surgery in chronic subdural hematoma (CSDH) patients is unclear, and practice differs between countries. At the Brigham and Women's Hospital (BWH) in Boston, Massachusetts, neurosurgeons frequently order routine postoperative CT scans, while the University Medical Center Utrecht (UMCU) in the Netherlands does not have this policy. The aim of this study was to compare the use of postoperative CT scans in CSDH patients between these hospitals and to evaluate whether there are differences in clinical outcomes.
METHODS: The authors collected data from both centers for 391 age- and sex-matched CSDH patients treated with burr hole surgery between January 1, 2002, and July 1, 2016, and compared the number of postoperative scans up to 6 weeks after surgery, the need for re-intervention, and postoperative neurological condition.
RESULTS: BWH patients were postoperatively scanned a median of 4 times (interquartile range [IQR] 2-5), whereas UMCU patients underwent a median of 0 scans (IQR 0-1, p < 0.001). There was no significant difference in the number of re-operations (20 in the BWH vs 27 in the UMCU, p = 0.34). All re-interventions were preceded by clinical decline and no recurrences were detected on scans performed on asymptomatic patients. Patients' neurological condition was not worse in the UMCU than in the BWH (p = 0.43).
CONCLUSIONS: While BWH patients underwent more scans than UMCU patients, there were no differences in clinical outcomes. The results of this study suggest that there is little benefit to routine scanning in asymptomatic patients who have undergone surgical treatment of uncomplicated CSDH and highlight opportunities to make practice more efficient.

Entities:  

Keywords:  BWH = Brigham and Women’s Hospital; CSDH = chronic subdural hematoma; CT; CT = computed tomography; IQR = interquartile range; UMCU = University Medical Center Utrecht; burr hole craniotomy; chronic subdural hematoma; computed tomography; practice variation; recurrence; trauma

Mesh:

Year:  2018        PMID: 30579282     DOI: 10.3171/2018.8.JNS181767

Source DB:  PubMed          Journal:  J Neurosurg        ISSN: 0022-3085            Impact factor:   5.115


  4 in total

1.  External validation and modification of the Oslo grading system for prediction of postoperative recurrence of chronic subdural hematoma.

Authors:  Sae-Yeon Won; Daniel Dubinski; Michael Eibach; Florian Gessler; Eva Herrmann; Fee Keil; Volker Seifert; Juergen Konczalla; Bedjan Behmanesh
Journal:  Neurosurg Rev       Date:  2020-02-28       Impact factor: 3.042

2.  Management of Peritonsillar Abscesses in Adults: Survey of Otolaryngologists in Canada and the United States.

Authors:  David Forner; Christopher W Noel; Amy Grant; Paul Hong; Martin Corsten; Vincent Wu; S Mark Taylor; Jonathan R B Trites; Matthew H Rigby
Journal:  OTO Open       Date:  2021-09-13

3.  International practice variation in perioperative laboratory testing in glioblastoma patients-a retrospective cohort study.

Authors:  Joeky T Senders; Sybren L N Maas; Kaspar Draaisma; John J McNulty; Joanna L Ashby; Imo Hofer; Wouter W van Solinge; Maarten Ten Berg; Tom J Snijders; Tatjana Seute; Pierre A Robe; William B Gormley; Timothy R Smith; Marike L D Broekman
Journal:  Acta Neurochir (Wien)       Date:  2022-01-07       Impact factor: 2.216

4.  National survey on the current practice and attitudes toward the management of chronic subdural hematoma.

Authors:  Dana C Holl; Jurre Blaauw; Erwin Ista; Clemens M F Dirven; Kuan H Kho; Korné Jellema; Niels A van der Gaag; Ishita P Miah; Heleen M den Hertog; Joukje van der Naalt; Bram Jacobs; Dagmar Verbaan; Suzanne Polinder; Hester F Lingsma; Ruben Dammers
Journal:  Brain Behav       Date:  2022-02-03       Impact factor: 2.708

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.